Equities

Genomma Lab Internacional SAB de CV

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Genomma Lab Internacional SAB de CV

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MXN)17.49
  • Today's Change-0.270 / -1.52%
  • Shares traded3.82m
  • 1 Year change-35.39%
  • Beta0.4749
Data delayed at least 20 minutes, as of Mar 03 2026 20:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of MXN
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue17,54118,60716,467
OPERATING EXPENSES
Cost of revenue total6,5196,6766,384
Selling, general and admin. expenses, total7,2928,0556,889
Depreciation/amortization------
Unusual expense(income)--(9.04)5.97
Other operating expenses, total(30)(37)(13)
Total operating expense13,78214,68413,266
Operating income3,7603,9223,201
Other, net(251)(363)(264)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes2,4342,8911,721
Provision for income taxes826800636
Net income after taxes1,6072,0911,085
Minority interest------
Net income before extra. Items1,6072,0911,085
Total extraordinary items--(598)(59)
Net income1,6071,4931,026
Inc.avail. to common excl. extra. Items1,6072,0911,085
Inc.avail. to common incl. extra. Items1,6071,4931,026
EPS RECONCILIATION
Basic/primary weighted average shares974978957
Basic/primary eps excl. extra items1.652.141.13
Basic/primary eps incl. extra items1.651.531.07
Dilution adjustment------
Diluted weighted average shares974978957
Diluted eps excl. extra items1.652.141.13
Diluted eps incl. extra items1.651.531.07
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.800.800.59
Gross dividend - common stock--800600
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental797888830
SUPPLEMENTAL INCOME
Depreciation, supplemental379122157
Total special items--(9.04)5.97
NORMALISED INCOME
Normalized income before taxes2,4342,8821,727
Effect of special items on income taxes--(2.5)2.21
Income tax excluding impact of special items826797638
Normalized income after tax1,6072,0851,089
Normalized income avail. to common1,6072,0851,089
Basic normalized EPS1.652.131.14
Diluted normalized EPS1.652.131.14
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.